Tumor PD-L1 expression and molecular profiling are not associated with immune checkpoint inhibitor-induced thyroid dysfunction in advanced NSCLC patients

Horesh, A; Pollack, R; Nechushtan, H; Dresner-Pollak, R; Neuman, T

Neuman, T (通讯作者)，Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel.;Neuman, T (通讯作者)，Hadassah Hebrew Univ, Med Ctr, Dept Pathol, Jerusalem, Israel.

PATHOLOGY & ONCOLOGY RESEARCH, 2023; 29 ():

Abstract

Background: Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of advanced non-small cell lung cancer (NSCLC), however are frequent......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索